HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Rugaard Jensen Selected Research

Melanoma (Melanoma, Malignant)

4/2010Preclinical antitumor activity of the orally available heat shock protein 90 inhibitor NVP-BEP800.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Rugaard Jensen Research Topics

Disease

9Neoplasms (Cancer)
01/2019 - 04/2003
3Breast Neoplasms (Breast Cancer)
04/2010 - 01/2008
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2013
1Melanoma (Melanoma, Malignant)
04/2010
1Pathologic Constriction (Stenosis)
03/2010
1Thrombosis (Thrombus)
03/2010
1Coronary Artery Disease (Coronary Atherosclerosis)
03/2010
1Atherosclerotic Plaque (Atheroma)
03/2010
1Carcinogenesis
01/2008

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2017 - 07/2006
2Pharmaceutical PreparationsIBA
11/2015 - 01/2008
2Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2013 - 01/2008
25- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
06/2013 - 01/2008
2Molecular Chaperones (Chaperone, Molecular)IBA
11/2012 - 08/2009
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2017
1Proto-Oncogene Proteins c-mdm2IBA
01/2017
1Tumor Suppressor Protein p53IBA
01/2017
1siremadlinIBA
01/2017
1ErbB Receptors (EGF Receptor)IBA
06/2013
1Tyrosine Kinase InhibitorsIBA
06/2013
1Biological ProductsIBA
06/2013
1NVP-BEP800IBA
04/2010
1Oxygen (Dioxygen)IBA
03/2010
1Biomarkers (Surrogate Marker)IBA
02/2010
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
04/2003
1CyclinsIBA
04/2003
1Cyclin G1IBA
04/2003

Therapy/Procedure

4Therapeutics
01/2019 - 03/2010
1Oral Administration
04/2010
1Stents
03/2010
1Drug-Eluting Stents
03/2010
1Aftercare (After-Treatment)
04/2003